These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35182704)

  • 1. Effect of pressure drop on the in vitro dispersion of adhesive mixtures of different blend states for inhalation.
    Rudén J; Frenning G; Bramer T; Thalberg K; Alderborn G
    Int J Pharm; 2022 Apr; 617():121590. PubMed ID: 35182704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between surface coverage ratio and powder mechanics of binary adhesive mixtures for dry powder inhalers.
    Rudén J; Frenning G; Bramer T; Thalberg K; Alderborn G
    Int J Pharm; 2018 Apr; 541(1-2):143-156. PubMed ID: 29454905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking carrier morphology to the powder mechanics of adhesive mixtures for dry powder inhalers via a blend-state model.
    Rudén J; Frenning G; Bramer T; Thalberg K; An J; Alderborn G
    Int J Pharm; 2019 Apr; 561():148-160. PubMed ID: 30825556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segregation in inhalable powders: Quantification of the effect of vibration on adhesive mixtures.
    Sarangi S; Simonsson A; Frenning G
    Eur J Pharm Biopharm; 2023 Jun; 187():107-119. PubMed ID: 37100091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance.
    Faulhammer E; Wahl V; Zellnitz S; Khinast JG; Paudel A
    Int J Pharm; 2015 Aug; 491(1-2):231-42. PubMed ID: 26136200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the relationship between blend state and dispersibility of adhesive mixtures containing active pharmaceutical ingredients.
    Rudén J; Frenning G; Bramer T; Thalberg K; Alderborn G
    Int J Pharm X; 2021 Dec; 3():100069. PubMed ID: 33409485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.
    Sun Y; Qin L; Li J; Su J; Song R; Zhang X; Guan J; Mao S
    AAPS J; 2021 Apr; 23(3):55. PubMed ID: 33856568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of drug load on the aerosolisation propensity of binary adhesive mixtures for inhalation.
    Simonsson A; Bramer T; Wimbush A; Alderborn G
    Int J Pharm; 2024 May; 657():124122. PubMed ID: 38621619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Powder flow analysis: A simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations.
    Hertel M; Schwarz E; Kobler M; Hauptstein S; Steckel H; Scherließ R
    Int J Pharm; 2018 Jan; 535(1-2):59-67. PubMed ID: 29100914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of lactose fine size and drug shape on rheological properties and aerodynamic behavior of dry powders for inhalation.
    Sun Y; Yu D; Li J; Zhao J; Feng Y; Zhang X; Mao S
    Eur J Pharm Biopharm; 2022 Oct; 179():47-57. PubMed ID: 36029939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor.
    Khan I; Al-Hasani A; Khan MH; Khan AN; -Alam FE; Sadozai SK; Elhissi A; Khan J; Yousaf S
    PLoS One; 2023; 18(3):e0281860. PubMed ID: 36913325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The match between adhesive mixture powder formulations for inhalation and the inhaler device.
    Thalberg K; Ahmadi R; Stuckel J; Elfman P; Svensson M
    Eur J Pharm Sci; 2023 Jul; 186():106457. PubMed ID: 37116546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
    Mönckedieck M; Kamplade J; Fakner P; Urbanetz NA; Walzel P; Steckel H; Scherließ R
    Int J Pharm; 2017 May; 524(1-2):351-363. PubMed ID: 28347847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry powder inhalers: study of the parameters influencing adhesion and dispersion of fluticasone propionate.
    Le VN; Hoang Thi TH; Robins E; Flament MP
    AAPS PharmSciTech; 2012 Jun; 13(2):477-84. PubMed ID: 22399285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spherical agglomerates of lactose as potential carriers for inhalation.
    Zellnitz S; Lamešić D; Stranzinger S; Pinto JT; Planinšek O; Paudel A
    Eur J Pharm Biopharm; 2021 Feb; 159():11-20. PubMed ID: 33358941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
    Hassoun M; Ho S; Muddle J; Buttini F; Parry M; Hammond M; Forbes B
    Int J Pharm; 2015 Jul; 490(1-2):360-7. PubMed ID: 25987210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capabilities and limitations of using powder rheology and permeability to predict dry powder inhaler performance.
    Cordts E; Steckel H
    Eur J Pharm Biopharm; 2012 Oct; 82(2):417-23. PubMed ID: 22902789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling dispersion of dry powders for inhalation. The concepts of total fines, cohesive energy and interaction parameters.
    Thalberg K; Berg E; Fransson M
    Int J Pharm; 2012 May; 427(2):224-33. PubMed ID: 22349053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.